156 related articles for article (PubMed ID: 16227783)
21. NK-associated regulatory receptors in a structured HAART interruption of HIV-1-positive individuals.
Luque J; Lozano JM; García-Jurado G; Soriano-Sarabia N; González R; Vallejo A; Leal M; Peña J
AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1037-42. PubMed ID: 18724804
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
23. Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.
Goodier MR; Imami N; Moyle G; Gazzard B; Gotch F
Clin Exp Immunol; 2003 Dec; 134(3):470-6. PubMed ID: 14632753
[TBL] [Abstract][Full Text] [Related]
24. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia.
Kottilil S; Shin K; Planta M; McLaughlin M; Hallahan CW; Ghany M; Chun TW; Sneller MC; Fauci AS
J Infect Dis; 2004 Apr; 189(7):1193-8. PubMed ID: 15031787
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.
Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS
Clin Exp Immunol; 2022 Dec; 210(2):163-174. PubMed ID: 36053502
[TBL] [Abstract][Full Text] [Related]
26. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
[TBL] [Abstract][Full Text] [Related]
28. Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex.
Sobanov Y; Glienke J; Brostjan C; Lehrach H; Francis F; Hofer E
Immunogenetics; 1999 Feb; 49(2):99-105. PubMed ID: 9887346
[TBL] [Abstract][Full Text] [Related]
29. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
[TBL] [Abstract][Full Text] [Related]
30. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
[TBL] [Abstract][Full Text] [Related]
31. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
32. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
33. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy.
Weber K; Meyer D; Grosse V; Stoll M; Schmidt RE; Heiken H
Immunobiology; 2000 Aug; 202(2):172-8. PubMed ID: 10993291
[TBL] [Abstract][Full Text] [Related]
35. Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells.
Lohwasser S; Hande P; Mager DL; Takei F
Eur J Immunol; 1999 Mar; 29(3):755-61. PubMed ID: 10092077
[TBL] [Abstract][Full Text] [Related]
36. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C
AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180
[TBL] [Abstract][Full Text] [Related]
37. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
[TBL] [Abstract][Full Text] [Related]
38. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
Borrego F; Masilamani M; Kabat J; Sanni TB; Coligan JE
Mol Immunol; 2005 Feb; 42(4):485-8. PubMed ID: 15607803
[TBL] [Abstract][Full Text] [Related]
39. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
40. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
